Share 'Exon-Skipping Trial Updates from Sarepta & Prosensa'
In the wake of promising exon-skipping trial announcements earlier this summer, PPMD has been fielding many questions from the community about upcoming trials. We reached out to both Sarepta and Prosensa for updates to share.
Sarepta provided the Duchenne patient community with a written update and webinar on their clinical program on Thursday, August 7. Regular updates on their…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this